TK1

Across TCGA pan-cancer cohorts, TK1 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of TK1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where TK1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types TK1 is over-expressed in tumor.

HNSC, CCRCC, and LSCC are the cancer types where TK1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TK1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	IV	+1.084	<.001	11	view →
CCRCC	All	II,III,IV	+0.882	<.001	11	view →
LSCC	Male	II,III,IV	+1.490	<.001	9	view →
LUAD	Male	II,III,IV	+0.906	<.001	9	view →
COAD	All	II,III,IV	+0.420	<.001	9	view →
PDAC	All	II,III,IV	+0.589	<.001	7	view →
OV	All	All	+0.519	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

TK1–HNSC

Open the HNSC breakdown →